Chemoinformaics analysis of Bicyclo[3.1.1]heptan-3-one
Molecular Weight | 110.156 | nRot | 0 |
Heavy Atom Molecular Weight | 100.076 | nRig | 9 |
Exact Molecular Weight | 110.073 | nRing | 3 |
Solubility: LogS | -1.164 | nHRing | 0 |
Solubility: LogP | 0.947 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 19.1599 |
nHD | 0 | BPOL | 10.9001 |
QED | 0.46 |
Synth | 3.698 |
Natural Product Likeliness | 1.004 |
NR-PPAR-gamma | 0.24 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.006 |
HIA | 0.004 |
CACO-2 | -4.511 |
MDCK | 0.0000324 |
BBB | 0.989 |
PPB | 0.39692 |
VDSS | 0.922 |
FU | 0.758024 |
CYP1A2-inh | 0.26 |
CYP1A2-sub | 0.358 |
CYP2c19-inh | 0.263 |
CYP2c19-sub | 0.407 |
CYP2c9-inh | 0.118 |
CYP2c9-sub | 0.694 |
CYP2d6-inh | 0.027 |
CYP2d6-sub | 0.329 |
CYP3a4-inh | 0.179 |
CYP3a4-sub | 0.213 |
CL | 14.172 |
T12 | 0.738 |
hERG | 0.009 |
Ames | 0.015 |
ROA | 0.015 |
SkinSen | 0.061 |
Carcinogencity | 0.147 |
EI | 0.988 |
Respiratory | 0.166 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.947026 |